Robert J. Carpenter
CIK: 0001021046
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMRX
Immuneering Corp
Director
Discretionary Trading P&L
Holdings
About CARPENTER ROBERT J
CARPENTER ROBERT J (SEC CIK 0001021046) files insider reports with the SEC as Director of Immuneering Corp (IMRX).
Signal8 holds 2 ownership filings by CARPENTER ROBERT J, all Form 4s, filed between Jun 16, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Jun 13, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CARPENTER ROBERT J's filings is in CAMBRIDGE, MA.
Recent filings by CARPENTER ROBERT J
Other insiders filing for Immuneering Corp (IMRX)
- Gengos Andrew, Chief Financial Officer
- Zeskind Benjamin J., PRESIDENT AND CEO
- Hall Brett Matthew, CHIEF SCIENTIFIC OFFICER
- Schall Thomas J., Director
- HAUSMAN DIANA, Director
- KEATING LAURIE, Director